300298 Sinocare Inc.
- 24.50
- +0.05+0.20%
Sinocare Inc. News
Sinocare Inc. (300298.SZ): Completed repurchase, spending a total of 84.9729 million yuan to repurchase 3.4215 million shares.
On August 6th, Gelunhui reported that Sinocare Inc. (300298.SZ) announced that as of August 6, 2024, the deadline for the implementation of the company's partial repurchase of shares had expired and the share repurchase plan had been completed. The actual repurchase time of the company is from August 11, 2023 to January 31, 2024. As of the date of announcement disclosure, the company has cumulatively repurchased 3,421,500 shares of the company's stock through the share repurchase dedicated securities account in centralized bidding trading, accounting for 0.61% of the total share capital of 564,265,375 shares of the company, with a maximum fill price of 26.75 yuan/share and a minimum fill price of 23 yuan/share.
Sinocare Inc.'s (SZSE:300298) Most Bullish Insider, CEO Shao Bo Li Must Be Pleased With the Recent 3.2% Gain
Is Sinocare (SZSE:300298) Using Too Much Debt?
Fu Pengbo's latest heavy stock has arrived, with two new companies added.
Ruicai Fund, managed by Fu Pengbo, released the Q2 report of Ruicai Growth Value Mixed Fund. Fu Pengbo's latest management scale is 18.686 billion yuan, and the top ten holdings in the second quarter are: China Mobile, CATL, Luxshare Precision Industry, Tencent, Suzhou Maxwell Technologies, Guanghui Energy, Hangzhou Great Star Industrial, Sinocare Inc., Wanhua Chemical Group, and Hygeia Health. Compared with the end of the first quarter holdings, Great Star Industrial and Hygeia Health became his top ten heavy positions in the second quarter; Fu Pengbo increased his positions in Suzhou Maxwell Technologies, Guanghui Energy, CATL, and Sinocare Inc.; reduced positions in China Mobile, Luxshare Precision Industry, Tencent, and Wanhua Chemical Group. Fu Pengbo wrote in the Q2 report
Sinocare (SZSE:300298) Has More To Do To Multiply In Value Going Forward
Sinocare Inc. (300298.SZ): Received a government subsidy of 22.986 million yuan.
On July 1st, Gelunhui reported that Sinocare Inc. (300298.SZ) received a notice from the Hunan Xiangjiang New Area Taxation Bureau of the State Administration of Taxation regarding the value-added tax refund for software products on June 28, 2024. It is expected to receive government subsidy funds of RMB 22,986,016.11 (22.98 million yuan), accounting for 8.08% of the net income attributable to shareholders of the listed company in the most recent audited period. As of the date of this announcement, the above-mentioned funds have not yet been received, forming accounts receivable. The above-mentioned government subsidies will be included in "other income" and are expected to have an impact on the 20 of the company.
Three Days Left To Buy Sinocare Inc. (SZSE:300298) Before The Ex-Dividend Date
Sinocare Inc. (300298.SZ) plans to distribute a dividend of 2 yuan per 10 shares, with ex-rights and ex-dividends on June 17th.
Sinocare Inc. (300298.SZ) announced that it intends to distribute annual equity to all shareholders in 2023, with a ratio of 10 shares for every...
Sannuo Biotech (300298.SZ): A total of 0.61% shares have been repurchased
Gelonghui, June 3, 丨 Sannuo Biotech (300298.SZ) announced that as of May 31, 2024, the company had repurchased 3,421,500 shares of the company's shares through a special stock repurchase account, accounting for 0.61% of the company's total share capital of 564,265,375 shares. The highest transaction price was 26.75 yuan/share, the minimum transaction price was 23.80 yuan/share, and the total transaction amount was 84.97.29 million yuan (excluding transaction fees).
Sinocare Inc.'s (SZSE:300298) Stock Is Going Strong: Have Financials A Role To Play?
Sinocare Inc.'s (SZSE:300298) Share Price Not Quite Adding Up
Sannuo Biotech (300298.SZ) has repurchased a total of 3.4215 million shares at a cost of 84.9729 million yuan
Sannuo Biotech (300298.SZ) announced that as of April 30, 2024, the company has passed a share repurchase exclusive...
Sinocare Inc.'s (SZSE:300298) Most Bullish Insider Is CEO Shao Bo Li, and Their Holdings Value Went up by 16% Last Week
Sannuo Biotech (300298.SZ) announced first-quarter results, net profit of 809.376 million yuan, an increase of 35.51% over the previous year
According to Zhitong Finance App, Sannuo Biotech (300298.SZ) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 1,014 billion yuan, an increase of 14.92%; net profit attributable to shareholders of listed companies was 809.376 million yuan, an increase of 35.51% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 77.5811 million yuan, an increase of 21.48% year on year; basic earnings per share were 0.1,457 yuan.
Sinocare's (SZSE:300298) Five-year Total Shareholder Returns Outpace the Underlying Earnings Growth
Sannuo Biotech (300298.SZ) has spent 84.97 million yuan to buy back 3.4215 million shares
According to Zhitong Finance App, Sannuo Biotech (300298.SZ) announced that as of March 31, 2024, the company had repurchased a total of 3.4215 million shares of the company's shares through a special stock repurchase account, accounting for 0.61% of the company's total share capital. The highest transaction price was 26.75 yuan/share, the minimum transaction price was 23.80 yuan/share, and the total transaction amount was 84.97 million yuan.
We Think Sinocare (SZSE:300298) Can Manage Its Debt With Ease
Calculating The Fair Value Of Sinocare Inc. (SZSE:300298)
Sannuo Biotech (300298.SZ): Repurchase 0.61% of shares at a cumulative cost of 84.97.29 million yuan
Gelonghui, March 5, 丨 Sannuo Biotech (300298.SZ) announced that as of February 29, 2024, the company had repurchased 3,421,500 shares of the company's shares through a special stock repurchase account, accounting for 0.61% of the company's total share capital of 564,265,373 shares. The highest transaction price was 26.75 yuan/share, the minimum transaction price was 23.80 yuan/share, and the total transaction amount was 84.97.29 million yuan (excluding transaction fees).
Changes in Hong Kong stocks | Ping An Good Doctor (01833) rose nearly 5% in the afternoon. The company reached deep strategic cooperation with Sannuo Biotech and Umile
Dr. Ping An (01833) rose nearly 5% in the afternoon. As of press release, it rose 3.78% to HK$12.62, with a turnover of HK$458.24,500.
Analysis
Price Target
No Data
